1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, October 2016 (p9)

Biological Therapy Analysis & Statistics, October 2016 (p9)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

241-270 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Head And Neck Cancer - Pipeline Review, H2 2016

Head And Neck Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

Head And Neck Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an ...

  • Industries : Healthcare, General Medicine and Specialty Medicine
  • Countries : United States
Ageing - Pipeline Review, H2 2016

Ageing - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Ageing - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ageing - Pipeline Review, H2 2016, provides an overview of the Ageing (Metabolic ...

  • Industries : Drug Discovery and Development, Biological Therapy, Therapy, Pharmaceutical
  • Countries : World
Angina (Angina Pectoris) - Pipeline Review, H2 2016

Angina (Angina Pectoris) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Angina (Angina Pectoris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glial Cell Line Derived Neurotrophic Factor (Astrocyte ...

  • Industries : Mental Health, Pathology, Biological Therapy
  • Countries : World, Europe
Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...

  • Industries : Biological Therapy
  • Countries : World
C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Recepto ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Epidermolysis Bullosa - Pipeline Review, H2 2016

Epidermolysis Bullosa - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology
  • Countries : United States
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hematopoietic Stem Cell Transplantation - ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation, Pathology, Biotechnology, Cancer, Healthcare
  • Countries : United States
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : World, Europe, North America
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Cancer
  • Countries : United States
Theravectys SA - Product Pipeline Review - 2016

Theravectys SA - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • October 2016
  • by Global Markets Direct

Theravectys SA - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Theravectys SA - Product Pipeline Review - 2016’, provides an overview of the Theravectys SA’s pharmaceutical research ...

  • Industries : Biological Therapy, Research and Development, Cancer, Pathology
  • Countries : World
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsing Remitting Multiple Sclerosis ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States, Europe, World
C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biological Therapy, Pathology
  • Countries : United States
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology
  • Countries : United States, World
Pathfinder Cell Therapy Inc (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy Inc (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2016
  • by GlobalData

Summary Pathfinder Cell Therapy Inc (Pathfinder) is a regenerative medicine company that develops novel based therapies. The company has discovered a new mammalian cell type which is able to stimulate ...

  • Industries : Biological Therapy
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing ...

  • Industries : Genetically Modified Organism, Biotechnology
  • Countries : World
Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)

Ribonucleic Acid Interference (RNAi) Technology Market: By Application (Research and Development, Therapeutics, Drug Discovery, Agriculture), By Tools (Design/Software, Delivery Based, Monitoring, Libraries) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • October 2016
  • by Industry ARC

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and ...

  • Industries : Biological Therapy
  • Countries : Asia
Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : World, Europe, North America
Biological Safety Testing Market Analysis By Product, By Application, By Test and Segment Forecasts to 2024

Biological Safety Testing Market Analysis By Product, By Application, By Test and Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The biological safety testing market is expected to reach USD 5.54 billion by 2024, according to a new report by Grand View Research, Inc. The biological safety testing market is primarily driven by exponential ...

  • Industries : Biological Therapy
  • Countries : World
Biological Safety Testing Market Analysis By Product (Reagents & Kits, Instruments, Services), By Application (Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Products, Vaccines & Therapeutics), By Test, And Segment Forecasts

Biological Safety Testing Market Analysis By Product (Reagents & Kits, Instruments, Services), By Application (Stem Cell, Tissue & Tissue-Based Products, Gene Therapy, Blood & Blood-Based Products, Vaccines & Therapeutics), By Test, And Segment Forecasts

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The biological safety testing market is expected to reach USD 5.54 billion by 2024, according to a new report by Grand View Research, Inc. The biological safety testing market is primarily driven by exponential ...

  • Industries : Biological Therapy
  • Countries : World
Cell Expansion Global Market - Forecast to 2022

Cell Expansion Global Market - Forecast to 2022

  • $ 4950
  • Industry report
  • October 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Cell expansion technology has been emerging as a promising therapeutic solution for many diseases and is used for engineering, replacing, or regenerating human tissues, cells, and organs to restore normal ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • Industry report
  • October 2016
  • by Igate Research

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The ...

  • Industries : Biopharmaceutical, Generic Drug, Biotechnology, Pharmaceutical
  • Countries : World
Global Biopreservation Market: Size, Trends & Forecasts (2016-2020)

Global Biopreservation Market: Size, Trends & Forecasts (2016-2020)

  • $ 900
  • Industry report
  • October 2016
  • by Daedal Research

Scope of the Report The report titled “Global Biopreservation Market: Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global biopreservation market by value and by segments. ...

  • Industries : Genomics
  • Countries : World
Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025

  • $ 4200
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Allergy Immunotherapy Market is poised to grow at a CAGR of around 8.2% from 2015 to 2025. Some of the prominent trends that the market is witnessing include unmet need for healthcare in developing ...

  • Industries : Biological Therapy
  • Countries : United States
Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Gene therapy has emerged as a promising treatment option for various diseases (primarily the ones that currently have no cure) including cancers, inherited disorders and some viral infections. ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Stem Cell Banking - Global Market Outlook (2016-2022)

Stem Cell Banking - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Stem Cell Banking Market is accounted for $1.42 billion in 2015 and is expected to reach $4.58 billion by 2022 growing at a CAGR of 18.2% during the forecast period. ...

  • Industries : Banking
  • Countries : World
Single-Cell Analysis - Global Market Outlook (2016-2022)

Single-Cell Analysis - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Single-Cell Analysis market is estimated at $1.22 billion in 2015 and is expected to reach $4.25 billion by 2022 growing at a CAGR of 19.5% from 2015 to 2022. Growing ...

  • Industries : Biological Therapy
  • Countries : World, Asia, Europe, North America
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 220
  • Industry report
  • October 2016
  • by La Merie Publishing

CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains information about TCR & CAR engineered T-cells and NK cells ...

  • Industries : Biological Therapy
Biopreservation - Global Market Outlook (2016-2022)

Biopreservation - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biopreservation Market is accounted for $2.17 billion in 2015 and is expected to reach $4.75 billion by 2022 growing at a CAGR of 11.84% during the forecast period. ...

  • Industries : Biological Therapy
  • Countries : World, Asia, North America, Europe

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.